• OPEN AN ACCOUNT
Indian Indices
Nifty
24,666.90 88.55
(0.36%)
Sensex
81,330.56 182.34
( 0.22%)
Bank Nifty
54,801.30 -139.55
( -0.25%)
Nifty IT
37,853.55 498.95
( 1.34%)
Global Indices
Nasdaq
42,160.14 -270.96
(-0.64%)
Dow Jones
5,907.19 42.00
(0.72%)
Hang Seng
38,121.59 -61.67
(-0.16%)
Nikkei 225
8,602.92 -2.06
(-0.02%)
Forex
USD-INR
84.87 -0.55
(-0.64%)
EUR-INR
94.53 -1.49
(-1.55%)
GBP-INR
112.13 -1.43
(-1.26%)
JPY-INR
0.58 -0.01
(-2.04%)

EQUITY - MARKET SCREENER

Kody Technolab Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
91666
INE0Q7P01013
29.1089275
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KODYTECH
229.14
1121.66
EPS(TTM)
Face Value()
Div & Yield %
3.84
10
0
 

n2n technologies ltd
Concord Drugs consolidated net profit declines 92.86% in the September 2024 quarter
Nov 14,2024
Net profit of Concord Drugs declined 92.86% to Rs 0.04 crore in the quarter ended September 2024 as against Rs 0.56 crore during the previous quarter ended September 2023. Sales rose 64.36% to Rs 12.36 crore in the quarter ended September 2024 as against Rs 7.52 crore during the previous quarter ended September 2023.

ParticularsQuarter Ended
Sep. 2024Sep. 2023% Var.
Sales12.367.52 64
OPM %7.1221.41 -
PBDT0.411.19 -66
PBT0.070.80 -91
NP0.040.56 -93